Phase I study of anti-CD3 x anti-EGFR-armed activated T-cells for treatment of advanced colorectal or pancreatic cancer

Authors
Category Primary study
JournalJournal of Clinical Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 9befef67fa561b7df9797e06e8eeccc313317034
First added on: Feb 07, 2025